PMID- 25110539 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140811 LR - 20211021 IS - 1918-3003 (Print) IS - 1918-3011 (Electronic) IS - 1918-3003 (Linking) VI - 6 IP - 5 DP - 2014 Oct TI - Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation. PG - 354-61 LID - 10.14740/jocmr1863w [doi] AB - BACKGROUND: Accumulating evidence suggests that inflammatory mechanisms play a central role in the development, progression and outcome of atherosclerosis. Recent evidence suggests that statins improve anti-inflammatory, anti-thrombotic and endothelial functions, along with their lipid-decreasing effects. We examined the effect of statins on endothelial function using biochemical markers of endothelial dysfunction and brachial artery flow-mediated dilatation (FMD). METHODS: Thirty male patients presenting with acute coronary syndrome (ACS) and 26 age-matched healthy control subjects aged 40 - 60 years who were not on any medication were enrolled in the study. The patient group was started on atorvastatin (40 mg/day) without consideration of their low-density lipoprotein (LDL)-cholesterol levels. Endothelin, sICAM and E-selectin from stored serum samples were measured using commercially available enzyme-linked immunosorbant assays (ELISAs). Endothelial function was assessed using brachial artery FMD. RESULTS: Prior to statin treatment, E-selectin, sICAM and endothelin levels, endothelial dysfunction markers, were 99.74 +/- 34.67 ng/mL, 568.8 +/- 149.0 ng/mL and 0.62 +/- 0.33 fmol/mL, respectively in the patient group. E-selectin and sICAM levels were significantly higher in the patients than in the control subjects (P < 0.001); however, endothelin levels were not significantly different between groups. Statin treatment significantly reduced E-selectin and sICAM levels (P < 0.001); however, the decrease in endothelin levels was not statistically significant. %FMD values were significantly increased after statin treatment (P = 0.005), and levels of C-reactive protein (CRP), an inflammation marker, were significantly reduced. CONCLUSION: Our results indicate that statins play an important role in treatment endothelial dysfunction by reducing adhesion of inflammatory cells. FAU - Altun, Ibrahim AU - Altun I AD - Department of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. FAU - Oz, Fahrettin AU - Oz F AD - Department of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. FAU - Arkaya, Selda Can AU - Arkaya SC AD - Department of Biochemistry, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. FAU - Altun, Ilknur AU - Altun I AD - Department of Radiology, Sisli Etfal Training and Research Hospital, Sisli-Istanbul, Turkey. FAU - Bilge, Ahmet Kaya AU - Bilge AK AD - Department of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. FAU - Umman, Berrin AU - Umman B AD - Department of Cardiology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. FAU - Turkoglu, Umit Mutlu AU - Turkoglu UM AD - Department of Biochemistry, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20140728 PL - Canada TA - J Clin Med Res JT - Journal of clinical medicine research JID - 101538301 PMC - PMC4125330 OTO - NOTNLM OT - Acute coronary syndrome OT - Adhesion molecules OT - Flow-mediated dilatation OT - Statins OT - Ultrasonography EDAT- 2014/08/12 06:00 MHDA- 2014/08/12 06:01 PMCR- 2014/07/28 CRDT- 2014/08/12 06:00 PHST- 2014/05/15 00:00 [accepted] PHST- 2014/08/12 06:00 [entrez] PHST- 2014/08/12 06:00 [pubmed] PHST- 2014/08/12 06:01 [medline] PHST- 2014/07/28 00:00 [pmc-release] AID - 10.14740/jocmr1863w [doi] PST - ppublish SO - J Clin Med Res. 2014 Oct;6(5):354-61. doi: 10.14740/jocmr1863w. Epub 2014 Jul 28.